A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study of ALA-3000, Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Subjects With Treatment-Resistant Depression (TRD)
NCT06965569 · COMPLETED · Phase 1
ReadTheTrial indexes 1 studies for Treatment Resistant Depression. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Treatment Resistant Depression.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
There are 1 clinical trials listed for Treatment Resistant Depression. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Treatment Resistant Depression trials are distributed across: Phase 1 (1).